Close Menu

NEW YORK - Swiss firm Novigenix said today that it is collaborating with radiopharmaceutical company RadioMedix to develop a precision oncology diagnostic for patients with neuroendocrine tumors. 

Under the agreement, Novigenix will create an immune-transcriptomic-based test using its proprietary LITOseek platform to monitor the effectiveness of a type of treatment, alpha and beta peptide receptor radionuclide therapy (PRRT), which RadioMedix is developing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The University of California, Berkeley's Jennifer Doudna reflects at Science on the anniversary of the announcement of the birth of twin girls who underwent genome editing.

By studying its enamel proteome, researchers have found the ancient ape Gigantopithecus blacki belongs to a sister clade to that of orangutans.

Bloomberg Businessweek discusses genomics with BGI's Wang Jian.

In Science this week: researchers find transplanting the gut microbiome in mice affects physiology, and more.